Lorriana E Leard

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Fatal diffuse alveolar damage in two lung transplant patients treated with cetuximab
    Lorriana E Leard
    Division of Pulmonary and Critical Care Medicine, University of California at San Francisco, San Francisco, California 94143 0111, USA
    J Heart Lung Transplant 26:1340-4. 2007
  2. ncbi Lung transplantation in patients with connective tissue disorders and esophageal dysmotility
    Warren J Gasper
    Department of Surgery, University of California, San Francisco, CA 94143 0790, USA
    Dis Esophagus 21:650-5. 2008
  3. ncbi Use of sublingual tacrolimus in lung transplant recipients
    Katherine D Watkins
    Department of Clinical Pharmacy, University of California, San Francisco, California 94143 0622, USA
    J Heart Lung Transplant 31:127-32. 2012
  4. ncbi An analysis of potential risk factors for early complications from fiberoptic bronchoscopy in lung transplant recipients
    Leah Smith
    Department of Medicine, Division of Pulmonary and Critical Care, University of California, San Francisco, CA 94143 0903, USA
    Transpl Int 25:172-8. 2012
  5. ncbi Rapidly progressive pulmonary venoocclusive disease in young women taking oral contraceptives
    Anatoly Urisman
    Department of Pathology, University of California San Francisco, San Francisco, CA 94143 0102, USA
    J Heart Lung Transplant 31:1031-6. 2012
  6. ncbi Gastroesophageal reflux in patients with idiopathic pulmonary fibrosis referred for lung transplantation
    Matthew P Sweet
    University of California San Francisco, Department of Surgery, San Francisco, Calif, USA
    J Thorac Cardiovasc Surg 133:1078-84. 2007
  7. ncbi Supratherapeutic anticoagulation from low-molecular-weight heparin in lung transplant recipients
    Jonathan P Singer
    Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Francisco, San Francisco, California 94143, USA
    J Heart Lung Transplant 29:1009-13. 2010

Collaborators

Detail Information

Publications7

  1. ncbi Fatal diffuse alveolar damage in two lung transplant patients treated with cetuximab
    Lorriana E Leard
    Division of Pulmonary and Critical Care Medicine, University of California at San Francisco, San Francisco, California 94143 0111, USA
    J Heart Lung Transplant 26:1340-4. 2007
    ..Both patients died shortly after initiation of cetuximab due to diffuse alveolar damage, suggesting that EGFR inhibitors should be used with extreme caution in lung transplant recipients...
  2. ncbi Lung transplantation in patients with connective tissue disorders and esophageal dysmotility
    Warren J Gasper
    Department of Surgery, University of California, San Francisco, CA 94143 0790, USA
    Dis Esophagus 21:650-5. 2008
    ..In conclusion, esophageal dysmotility and reflux are common in CTD patients referred for lung transplant. For this group, laparoscopic fundoplication is safe in experienced hands...
  3. ncbi Use of sublingual tacrolimus in lung transplant recipients
    Katherine D Watkins
    Department of Clinical Pharmacy, University of California, San Francisco, California 94143 0622, USA
    J Heart Lung Transplant 31:127-32. 2012
    ..We aimed to identify a dose conversion ratio between oral and sublingual tacrolimus in LTRs...
  4. ncbi An analysis of potential risk factors for early complications from fiberoptic bronchoscopy in lung transplant recipients
    Leah Smith
    Department of Medicine, Division of Pulmonary and Critical Care, University of California, San Francisco, CA 94143 0903, USA
    Transpl Int 25:172-8. 2012
    ..30). The involvement of trainees, pre-transplant diagnosis, and transplant type do not significantly impact the rate of bronchoscopic complications in lung transplant recipients...
  5. ncbi Rapidly progressive pulmonary venoocclusive disease in young women taking oral contraceptives
    Anatoly Urisman
    Department of Pathology, University of California San Francisco, San Francisco, CA 94143 0102, USA
    J Heart Lung Transplant 31:1031-6. 2012
    ..The temporal sequence in these 2 patients suggests the thrombogenic action of OCs may contribute to the development of PVOD, with or without underlying connective tissue disease...
  6. ncbi Gastroesophageal reflux in patients with idiopathic pulmonary fibrosis referred for lung transplantation
    Matthew P Sweet
    University of California San Francisco, Department of Surgery, San Francisco, Calif, USA
    J Thorac Cardiovasc Surg 133:1078-84. 2007
    ..The aims of this study were to determine in patients with idiopathic pulmonary fibrosis (1) the prevalence of reflux symptoms, (2) the esophageal manometric profile, and (3) the prevalence of proximal and distal esophageal reflux...
  7. ncbi Supratherapeutic anticoagulation from low-molecular-weight heparin in lung transplant recipients
    Jonathan P Singer
    Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Francisco, San Francisco, California 94143, USA
    J Heart Lung Transplant 29:1009-13. 2010
    ..Having identified a high incidence of supratherapeutic anti-factor Xa levels in lung transplant recipients, we aimed to elucidate the relationship between enoxaparin dose and anti-factor Xa level in this patient population...